Alexander P.
- Country
- Germany
- Department
- Medizinische Klinik und Poliklinik II / Spezialambulanz Gastrointestinale- und Lebertumoren
Research Overview
- Phase II Open-Label Study of Pembrolizumab and Lenvatinib in Advanced Hepatocellular Carcinoma Refractory to Atezolizumab and Bevacizumab Therapy
- Phase III Randomized Study of Durvalumab and Tremelimumab Versus Sorafenib in First-Line Treatment of Unresectable Advanced Hepatocellular Carcinoma
- Phase III Randomized Double-Blind Study of Rilvegostomig Plus Chemotherapy in Adjuvant Treatment of Resected Biliary Tract Adenocarcinoma
Data & Insights
Has run more than one trial at 34 of 103 partner sites.
Specializations
Hepatocellular Carcinoma Treatment
This investigator specializes in treating advanced hepatocellular carcinoma (HCC), with particular focus on both resectable and unresectable liver cancer cases. Their research encompasses innovative therapeutic approaches using immunotherapy combinations and targeted treatments.
- First-line Treatment Strategies
- Combination Immunotherapy Approaches
- Post-surgical Recurrence Prevention
Their work extends to developing treatment options for patients who have become refractory to standard therapies.
Interventional Oncology
The investigator explores integrated treatment approaches combining systemic therapies with local interventions. Their research includes studying the effectiveness of transarterial chemoembolization (TACE) in conjunction with contemporary immunotherapy protocols.
- Selective TACE Procedures
- Combined Systemic-Local Treatments
- Therapeutic Sequencing Strategies
Their work focuses on optimizing treatment timing and combinations for maximum therapeutic benefit.
Biliary Tract Cancer Research
The investigator conducts research in biliary tract cancers, including cholangiocarcinoma and gallbladder cancer. Their work encompasses post-surgical adjuvant therapy approaches and novel therapeutic combinations.
- Intrahepatic Cholangiocarcinoma
- Extrahepatic Bile Duct Cancer
- Post-Resection Treatment Strategies
Their research aims to improve outcomes in surgically treated biliary tract cancer patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.